Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SURGAR

Explore full profile

A real time augmented reality software based on artificial intelligence and computer vision to increase surgical procedures’ effectiveness and efficiency

Clermont-Ferrand, FranceFounded 2019Health Tech & Medtech
Valuation $50–100M Last recorded · 2024
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for SURGAR and the history behind them.

About SURGAR

SURGAR is a French company founded in 2019 that specializes in the development of medical devices, specifically software leveraging augmented reality (AR) and artificial intelligence (AI) to support minimally invasive surgery. The company's core product is a software platform that provides surgeons with real-time, automated visualization of a patient's internal anatomical structures, such as vessels and arteries, during surgical procedures. This is achieved by overlaying 3D models, generated from medical imaging, onto the live endoscopic view.

The company's business model is centered on providing this software to hospitals and surgical centers. The target clients are surgeons and healthcare institutions performing minimally invasive surgeries. By enhancing the surgeon's view and providing critical information directly within the operative field, SURGAR aims to improve surgical precision, reduce procedure time, and enhance patient safety. The company operates in the growing MedTech market, specifically in the surgical technology and medical imaging sectors.

SURGAR has recently secured significant funding, including an €11 million round, to accelerate the development and commercialization of its AR surgical solutions. This capital injection will support the expansion of its team, further technological advancements, and the deployment of its platform in more healthcare facilities. The company has also established strategic partnerships, such as with the Grenoble Alpes University Hospital, to co-develop and validate its technology in a clinical setting.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2019
Headquarters
Clermont-Ferrand, France
Employees
42
Open positions
None listed
Dealroom signal
63.9/100
Industry
Health
Sub-industry
Medical Devices, Health Platform
Sector
Health Tech & Medtech, Surgery, Medical Education, Medical Imaging
Technology
Artificial Intelligence, Deep Tech, Augmented Reality, Virtual Reality, Computer Vision, Connected Device
Business model
SaaS
Client focus
b2b

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Sep 2024 $12M $48M Elaia · Crédit Agricole · Mutuelles Impact · Bpifrance ↗
SUPPORT PROGRAM✓Other financing Jan 2022 $2K — EIT Health —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

SURGAR website traffic

Latest recorded traffic for SURGAR is 530 monthly website visits, up 89.3% over the last three months. SURGAR's team declined 10.6% over the past year.

Latest monthly visits530 3-month web change+89.3% 1-year team growth-10.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Crédit Agricole
  • Kreaxi
  • Sofimac Régions
  • EIT Health

Series A6 investors entered at this stage

  • Mutuelles Impact
  • Elaia
  • Bpifrance
  • Malakoff Humanis
  • UI Investissement
  • Jacques Gardette

Other known investors2 additional known investors

  • Clermont Auvergne University
  • Clermont Auvergne Innovation
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇫🇷 France97.4%
🇮🇹 Italy2.6%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SURGAR on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SURGAR’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.